Growth Opportunities Leverage recent product expansions and acquisitions, such as MX908 capabilities and the NIRLAB Sarl acquisition, to cross-sell enhanced trace chemical identification solutions to existing customers in forensics, bioprocessing, and life sciences.

Commercial Momentum Capitalize on the revenue beat and positive near-term profitability signals to engage investors and potential enterprise clients about scalable handheld and desktop analytics for on-site chemical analysis and rapid decision-making.

Defense & Security Target security and investigations teams with VipIR and MX908 capabilities for unknown material identification, offering streamlined workflows, software automation, and ML-driven insights to shorten incident response times.

Strategic Partnerships Propose partnerships with larger analytical players (through channel alliances or OEM collaborations) to expand distribution, integration with existing lab ecosystems, and adoption of 908 Devices’ microfluidic and analytical technology across new verticals.

Global Expansion Highlight international expansion potential following the NIRLAB acquisition and Lausanne-based capabilities, focusing on multilingual support, regulatory-compliant solutions, and localized service offerings to win global contracts.